Agios Pharm Stock Price on November 28, 2025
| AGIO Stock | USD 27.73 0.31 1.13% |
If you're considering investing in Agios Stock, it is important to understand the factors that can impact its price. As of today, the current price of Agios Pharm stands at 27.73, as last reported on the 7th of December, with the highest price reaching 27.95 and the lowest price hitting 27.06 during the day. Agios Pharm secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. Agios Pharm exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Agios Pharm's Standard Deviation of 6.93, mean deviation of 2.81, and Risk Adjusted Performance of 0.0036 to double-check the risk estimate we provide. At this time, Agios Pharm's Total Stockholder Equity is very stable compared to the past year. As of the 7th of December 2025, Liabilities And Stockholders Equity is likely to grow to about 1.7 B, while Common Stock Total Equity is likely to drop about 49.5 K. . As of the 7th of December 2025, Price Earnings Ratio is likely to grow to 2.91, while Price To Sales Ratio is likely to drop 32.84. Agios Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Price Book 1.2591 | Enterprise Value Ebitda (2.33) | Price Sales 36.1019 | Shares Float 51.6 M | Wall Street Target Price 32.125 |
Related Headline
Sun Country Headline on 28th of November 2025
Analysts Set Sun Country Airlines Holdings, Inc. PT at 19.43 by thelincolnianonline.com
Shares of Sun Country Airlines Holdings, Inc. have been given a consensus recommendation of Moderate Buy by the nine analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy
Agios Pharm Valuation on November 28, 2025
It is possible to determine the worth of Agios Pharm on a given historical date. On November 28, 2025 Agios was worth 29.3 at the beginning of the trading date compared to the closed value of 29.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Agios Pharm stock. Still, in general, we apply an absolute valuation method to find Agios Pharm's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Agios Pharm where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Agios Pharm's related companies.
| Open | High | Low | Close | Volume | |
| 28.85 | 29.46 | 27.84 | 29.04 | 1,856,330 | |
11/28/2025 | 29.30 | 29.30 | 28.45 | 29.20 | 500,589 |
| 28.51 | 28.55 | 27.63 | 27.84 | 1,492,560 |
| Backtest Agios Pharm | | | Agios Pharm History | | | Agios Pharm Valuation | Previous | Next |
Agios Pharm Trading Date Momentum on November 28, 2025
| On December 01 2025 Agios Pharm was traded for 27.84 at the closing time. The top price for the day was 28.55 and the lowest listed price was 27.63 . The trading volume for the day was 1.5 M. The trading history from December 1, 2025 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.66% . The overall trading delta against the current closing price is 5.62% . |
Agios Pharm Fundamentals Correlations and Trends
By evaluating Agios Pharm's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Agios Pharm's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Agios financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Agios Pharm Stock history
Agios Pharm investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Agios is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Agios Pharm will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Agios Pharm stock prices may prove useful in developing a viable investing in Agios Pharm
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 57.9 M | 49.8 M | |
| Net Loss | -266.6 M | -253.2 M |
Agios Pharm Quarterly Net Working Capital |
|
Agios Pharm Stock Technical Analysis
Agios Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Agios Pharm Period Price Range
Low | December 7, 2025
| High |
0.00 | 0.00 |
Agios Pharm cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Agios Pharm December 7, 2025 Market Strength
Market strength indicators help investors to evaluate how Agios Pharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Agios Pharm shares will generate the highest return on investment. By undertsting and applying Agios Pharm stock market strength indicators, traders can identify Agios Pharm entry and exit signals to maximize returns
Agios Pharm Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Agios Pharm's price direction in advance. Along with the technical and fundamental analysis of Agios Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Agios to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0036 | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | (0.04) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.01) | Revenue Per Share | Quarterly Revenue Growth 0.437 | Return On Assets | Return On Equity |
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.